A novel NFKB1 agonist remodels tumor microenvironment and activates dendritic cells to promote anti-tumor immunity in colorectal cancer
Abstract Background The immunosuppressive nature of the tumor microenvironment (TME) and the existence of cancer stem cells (CSCs) present significant hurdles in tumor therapy. The identification of therapeutic agents that can target both CSCs and the TME could be a potential approach to overcome tr...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2025-05-01
|
| Seri Bilgileri: | Journal of Translational Medicine |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12967-025-06576-2 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|